(Asn23)-Amyloid beta-Protein (1-40) incorporates an asparagine substitution at position 23 to modulate peptide aggregation and stability. The modification alters the peptide's propensity to form amyloid fibrils, making it useful for studying neurodegenerative diseases like Alzheimer's. Researchers use it to explore the early stages of amyloid plaque formation and investigate strategies to prevent amyloid-related toxicity.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More